{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:00:44Z","timestamp":1768960844224,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00748-4","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:02:24Z","timestamp":1768640544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic potential of [(8-hydroxyquinolin-7-yl)(phenyl)methylamino] benzoic acid regioisomers against human-intoxicating botulinum neurotoxin serotypes: computational modeling to in vivo protection"],"prefix":"10.1007","volume":"40","author":[{"given":"Surabhi","family":"Agnihotri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinita Chauhan","family":"Kushwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha","family":"Disoriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Kumar","family":"Dhaked","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"748_CR1","doi-asserted-by":"publisher","unstructured":"Arnon SS, Schechter R, Inglesby TV, et al. (2001) Botulinum toxin as a biological weapon: medical and public health management [published correction appears in JAMA 2001 Apr 25; 285(16):2081].\u00a0JAMA 285(8):1059\u20131070. https:\/\/doi.org\/10.1001\/jama.285.8.1059","DOI":"10.1001\/jama.285.8.1059"},{"key":"748_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-33570-9_1","volume":"364","author":"KK Hill","year":"2013","unstructured":"Hill KK, Smith TJ (2013) Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters, and toxin subtypes. Curr Top Microbiol Immunol 364:1\u201320. https:\/\/doi.org\/10.1007\/978-3-642-33570-9_1","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"748_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/toxins12010017","volume":"12","author":"C Rasetti-Escargueil","year":"2020","unstructured":"Rasetti-Escargueil C, Lemichez E, Popoff MR (2020) Public health risk associated with botulism as foodborne zoonoses. Toxins 12(1):17. https:\/\/doi.org\/10.3390\/toxins12010017","journal-title":"Toxins"},{"issue":"6","key":"748_CR4","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00204-022-03271-9","volume":"96","author":"M Pirazzini","year":"2022","unstructured":"Pirazzini M, Montecucco C, Rossetto O (2022) Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. Arch Toxicol 96(6):1521\u20131539. https:\/\/doi.org\/10.1007\/s00204-022-03271-9","journal-title":"Arch Toxicol"},{"issue":"4","key":"748_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1017\/s0033583500003292","volume":"28","author":"C Montecucco","year":"1995","unstructured":"Montecucco C, Schiavo G (1995) Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 28(4):423\u2013472. https:\/\/doi.org\/10.1017\/s0033583500003292","journal-title":"Q Rev Biophys"},{"issue":"32","key":"748_CR6","doi-asserted-by":"publisher","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","volume":"268","author":"G Schiavo","year":"1993","unstructured":"Schiavo G, Rossetto O, Catsicas S et al (1993) Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268(32):23784\u201323787","journal-title":"J Biol Chem"},{"issue":"16","key":"748_CR7","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.1016\/S0021-9258(19)50230-7","volume":"268","author":"G Schiavo","year":"1993","unstructured":"Schiavo G, Shone CC, Rossetto O et al (1993) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP\/synaptobrevin. J Biol Chem 268(16):11516\u201311519","journal-title":"J Biol Chem"},{"issue":"8","key":"748_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1023\/a:1020687430927","volume":"18","author":"Y Sagane","year":"1999","unstructured":"Sagane Y, Watanabe T, Kouguchi H et al (1999) Dichain structure of botulinum neurotoxin: identification of cleavage sites in types C, D, and F neurotoxin molecules. J Protein Chem 18(8):885\u2013892. https:\/\/doi.org\/10.1023\/a:1020687430927","journal-title":"J Protein Chem"},{"issue":"7","key":"748_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2174\/1568026615666150309150338","volume":"15","author":"G Kumar","year":"2015","unstructured":"Kumar G, Swaminathan S (2015) Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins. Curr Top Med Chem 15(7):685\u2013695. https:\/\/doi.org\/10.2174\/1568026615666150309150338","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"748_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/444507","volume":"41","author":"J Sobel","year":"2005","unstructured":"Sobel J (2005) Botulism. Clin Infect Dis 41(8):1167\u20131173. https:\/\/doi.org\/10.1086\/444507","journal-title":"Clin Infect Dis"},{"issue":"1-2","key":"748_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","volume":"109","author":"AS Burgen","year":"1949","unstructured":"Burgen AS, Dickens F, Zatman LJ (1949) The action of botulinum toxin on the neuro-muscular junction. J Physiol 109(1\u20132):10\u201324. https:\/\/doi.org\/10.1113\/jphysiol.1949.sp004364","journal-title":"J Physiol"},{"key":"748_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-022-00487-4","author":"JB Machamer","year":"2022","unstructured":"Machamer JB, Vazquez-Cintron EJ, O\u2019Brien SW et al (2022) Antidotal treatment of botulism in rats by continuous infusion with 3, 4-diaminopyridine. Mol Med. https:\/\/doi.org\/10.1186\/s10020-022-00487-4","journal-title":"Mol Med"},{"issue":"18","key":"748_CR13","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1016\/j.bmc.2016.06.036","volume":"24","author":"G Kumar","year":"2016","unstructured":"Kumar G, Agarwal R, Swaminathan S (2016) Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: structure-activity relationship and a pharmacophore model. Bioorg Med Chem 24(18):3978\u20133985. https:\/\/doi.org\/10.1016\/j.bmc.2016.06.036","journal-title":"Bioorg Med Chem"},{"issue":"18","key":"748_CR14","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1039\/c2cc17158a","volume":"48","author":"G Kumar","year":"2012","unstructured":"Kumar G, Agarwal R, Swaminathan S (2012) Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening. Chem Commun (Camb) 48(18):2412\u20132414. https:\/\/doi.org\/10.1039\/c2cc17158a","journal-title":"Chem Commun (Camb)"},{"issue":"3","key":"748_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s0014-5793(98)00492-x","volume":"429","author":"M Adler","year":"1998","unstructured":"Adler M, Nicholson JD, Cornille F et al (1998) Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity. FEBS Lett 429(3):234\u2013238. https:\/\/doi.org\/10.1016\/s0014-5793(98)00492-x","journal-title":"FEBS Lett"},{"key":"748_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2022.106981","volume":"222","author":"R Chauhan","year":"2023","unstructured":"Chauhan R, Chauhan Kushwah V, Agnihotri S et al (2023) Designing, synthesis, and evaluation of derived analogues of selected small molecule non-peptidic inhibitors against serotype BoNT\/ F. Toxicon 222:106981. https:\/\/doi.org\/10.1016\/j.toxicon.2022.106981","journal-title":"Toxicon"},{"issue":"8","key":"748_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/acscombsci.6b00033","volume":"18","author":"KM Bompiani","year":"2016","unstructured":"Bompiani KM, Cagli\u010d D, Krutein MC et al (2016) High-throughput screening uncovers novel botulinum neurotoxin inhibitor chemotypes. ACS Comb Sci 18(8):461\u2013474. https:\/\/doi.org\/10.1021\/acscombsci.6b00033","journal-title":"ACS Comb Sci"},{"key":"748_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.toxicon.2015.02.012","volume":"98","author":"VA Montgomery","year":"2015","unstructured":"Montgomery VA, Ahmed SA, Olson MA et al (2015) Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors. Toxicon 98:12\u201319. https:\/\/doi.org\/10.1016\/j.toxicon.2015.02.012","journal-title":"Toxicon"},{"issue":"3","key":"748_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/jm4012164","volume":"57","author":"D Cagli\u010d","year":"2014","unstructured":"Cagli\u010d D, Krutein MC, Bompiani KM et al (2014) Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain. J Med Chem 57(3):669\u2013676. https:\/\/doi.org\/10.1021\/jm4012164","journal-title":"J Med Chem"},{"key":"748_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103297","volume":"92","author":"R Chauhan","year":"2019","unstructured":"Chauhan R, Chauhan V, Sonkar P et al (2019) Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F. Bioorg Chem 92:103297. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103297","journal-title":"Bioorg Chem"},{"key":"748_CR21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00044-024-03272-6","volume":"33","author":"S Agnihotri","year":"2024","unstructured":"Agnihotri S, Kushwah VC, Bansal S et al (2024) Novel 2-[(8-hydroxyquinolin-7-yl)(phenyl) methylamino]benzoic acid analogs targeting the active site of botulinum neurotoxins: designing, synthesis, and biological evaluation. Med Chem Res 33:1625\u20131642. https:\/\/doi.org\/10.1007\/s00044-024-03272-6","journal-title":"Med Chem Res"},{"issue":"12","key":"748_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2174\/092986611797642689","volume":"18","author":"P Singh","year":"2011","unstructured":"Singh P, Singh MK, Chauhan V et al (2011) Prevention of aggregation and autocatalysis for sustaining biological activity of recombinant BoNT\/A-LC upon long-term storage. Protein Pept Lett 18(12):1177\u20131187. https:\/\/doi.org\/10.2174\/092986611797642689","journal-title":"Protein Pept Lett"},{"issue":"1","key":"748_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70929-8","volume":"10","author":"P Sonkar","year":"2020","unstructured":"Sonkar P, Chauhan V, Chauhan R et al (2020) Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E. Sci Rep 10(1):13932. https:\/\/doi.org\/10.1038\/s41598-020-70929-8","journal-title":"Sci Rep"},{"issue":"3","key":"748_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Epidemiol 27(3):493\u2013497. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118408","journal-title":"Am J Epidemiol"},{"issue":"575","key":"748_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd7789","volume":"13","author":"PM McNutt","year":"2021","unstructured":"McNutt PM, Vazquez-Cintron EJ, Tenezaca L et al (2021) Neuronal delivery of antibodies has therapeutic effects in animal models of botulism. Sci Transl Med 13(575):abd7789. https:\/\/doi.org\/10.1126\/scitranslmed.abd7789","journal-title":"Sci Transl Med"},{"issue":"575","key":"748_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz4197","volume":"13","author":"SI Miyashita","year":"2021","unstructured":"Miyashita SI, Zhang J, Zhang S et al (2021) Delivery of single-domain antibodies into neurons using a chimeric toxin-based platform is therapeutic in mouse models of botulism. Sci Transl Med 13(575):eaaz4197. https:\/\/doi.org\/10.1126\/scitranslmed.aaz4197","journal-title":"Sci Transl Med"},{"key":"748_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-642-33570-9_4","volume":"364","author":"A Rummel","year":"2013","unstructured":"Rummel A (2013) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 364:61\u201390. https:\/\/doi.org\/10.1007\/978-3-642-33570-9_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"748_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jms.2016.10.020","volume":"332","author":"AP Cismesia","year":"2017","unstructured":"Cismesia AP, Nicholls GR, Polfer NC (2017) Amine vs. carboxylic acid protonation in ortho-, meta-, and para-aminobenzoic acid: an IRMPD spectroscopy study. J Mol Spectrosc 332:79\u201385. https:\/\/doi.org\/10.1016\/j.jms.2016.10.020","journal-title":"J Mol Spectrosc"},{"issue":"21","key":"748_CR29","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1021\/bi036278w","volume":"43","author":"R Agarwal","year":"2004","unstructured":"Agarwal R, Eswaramoorthy S, Kumaran D et al (2004) Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212\u2013>Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway. Biochemistry 43(21):6637\u20136644. https:\/\/doi.org\/10.1021\/bi036278w","journal-title":"Biochemistry"},{"issue":"35","key":"748_CR30","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1021\/bi0510072","volume":"44","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Binz T, Swaminathan S (2005) Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. Biochemistry 44(35):11758\u201311765. https:\/\/doi.org\/10.1021\/bi0510072","journal-title":"Biochemistry"},{"issue":"1","key":"748_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0014-5793(98)01041-2","volume":"435","author":"JJ Schmidt","year":"1998","unstructured":"Schmidt JJ, Stafford RG, Bostian KA (1998) Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1\u2019 binding subsite. FEBS Lett 435(1):61\u201364. https:\/\/doi.org\/10.1016\/s0014-5793(98)01041-2","journal-title":"FEBS Lett"},{"issue":"22","key":"748_CR32","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1021\/jm0300680","volume":"46","author":"C Anne","year":"2003","unstructured":"Anne C, Turcaud S, Quancard J et al (2003) Development of potent inhibitors of botulinum neurotoxin type B. J Med Chem 46(22):4648\u20134656. https:\/\/doi.org\/10.1021\/jm0300680","journal-title":"J Med Chem"},{"issue":"16","key":"748_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168577","volume":"22","author":"A Ben David","year":"2021","unstructured":"Ben David A, Barnea A, Diamant E et al (2021) Small molecule receptor binding inhibitors with in vivo efficacy against botulinum neurotoxin serotypes A and E. Int J Mol Sci 22(16):8577. https:\/\/doi.org\/10.3390\/ijms22168577","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00748-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:02:25Z","timestamp":1768640545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00748-4","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No human experiments were involved. However, approval for animal experiments was taken by the Institutional Animal Ethics Committee of DRDE, as mentioned in the Methods Section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"49"}}